Withdrawn
Phase 3
Age: 28Days - 2Years
All Genders
ID00000741
A Controlled Randomized Trial to Study the Efficacy of Adjunctive Methylprednisolone for the Treatment of Pneumocystis Carinii Pneumonia PCP in Pediatric AIDS Patients
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2021-11-04
N/A
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
To determine the effect of methylprednisolone on respiratory failure in HIV-infected patients with presumed or confirmed pneumocystis carinii pneumonia who are stratified for presence or absence of respiratory failure at the time of randomization to the study.
CONDITIONS
Brief Title
The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here